Liposome Drug Delivery Market Trends

  • Report ID: 4073
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT
  1. Market Definition
    1. Definition
    2. Market Segmentation
  2. Assumptions and Acronyms
  3. Research Methodology
    1. Research Process
    2. Primary Research
    3. Secondary Research
  4. Executive Summary – Global Liposome Drug Delivery Market
  5. Market Dynamics
    1. Drivers
    2. Challenges
    3. Trends
    4. Opportunities
  6. Pipeline Analysis
  7. Clinically Marketed Liposome Drugs
  8. Regulatory Scenario Assessment
  9. Analysis on Lipid Nanoparticles
  10. Competitive Landscape
    1. Market Share Analysis, 2021
    2. Company Profiles
      1. Pharmaceutical Formulation Manufacturers
        1. Spectrum Pharmaceuticals, Inc.
        2. Gilead Sciences, Inc.
        3. Celsion Corporation
        4. Ipsen Pharma
        5. Pacira Pharmaceuticals, Inc.
        6. Novartis AG
        7. CordenPharma International
        8. FUJIFILM Toyama Chemical Co., Ltd.
        9. Takeda Pharmaceutical Company Limited
        10. Johnson & Johnson Services, Inc.
        11. Astellas Pharma Inc.
        12. Elan Pharmaceuticals (Perrigo Company plc)
        13. Merrimack Pharmaceuticals, Inc.
        14. Janssen Pharmaceuticals, Inc.
      2. Raw Material Manufacturers
        1. NIPPON FINE CHEMICAL CO., LTD.
        2. Sonic Biochem Extractions Pvt. Ltd.
        3. Croda International Plc
        4. Lipoid GmbH
        5. Hashimoto Electronic Industry Co., LTD
  11. Global Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
        1. Liposomal Doxorubicin, 2023-2036F (USD Million)
        2. Liposomal Paclitaxel, 2023-2036F (USD Million)
        3. Liposomal Amphotericin, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      2. Technology
        1. Stealth Liposome Technology, 2023-2036F (USD Million)
        2. Non-PEGylated Liposome Technology, 2023-2036F (USD Million)
        3. DepoFoam Liposome Technology, 2023-2036F (USD Million)
      3. Application
        1. Fungal Diseases, 2023-2036F (USD Million)
        2. Pain Management, 2023-2036F (USD Million)
        3. Cancer Therapy, 2023-2036F (USD Million)
        4. Viral Vaccines, 2023-2036F (USD Million)
        5. Photodynamic Therapy, 2023-2036F (USD Million)
        6. Others, 2023-2036F (USD Million)
      4. Region
        1. North America, 2023-2036F (USD Million)
        2. Europe, 2023-2036F (USD Million)
        3. Asia Pacific, 2023-2036F (USD Million)
        4. Latin America, 2023-2036F (USD Million)
        5. Middle East & Africa, 2023-2036F (USD Million)
  12. North America Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
        1. Liposomal Doxorubicin, 2023-2036F (USD Million)
        2. Liposomal Paclitaxel, 2023-2036F (USD Million)
        3. Liposomal Amphotericin, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      2. Technology
        1. Stealth Liposome Technology, 2023-2036F (USD Million)
        2. Non-PEGylated Liposome Technology, 2023-2036F (USD Million)
        3. DepoFoam Liposome Technology, 2023-2036F (USD Million)
      3. Application
        1. Fungal Diseases, 2023-2036F (USD Million)
        2. Pain Management, 2023-2036F (USD Million)
        3. Cancer Therapy, 2023-2036F (USD Million)
        4. Viral Vaccines, 2023-2036F (USD Million)
        5. Photodynamic Therapy, 2023-2036F (USD Million)
        6. Others, 2023-2036F (USD Million)
      4. Country
        1. United States, 2023-2036F (USD Million)
        2. Canada, 2023-2036F (USD Million)
  13. Europe Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. Germany, 2023-2036F (USD Million)
        2. United Kingdom, 2023-2036F (USD Million)
        3. France, 2023-2036F (USD Million)
        4. Italy, 2023-2036F (USD Million)
        5. Spain, 2023-2036F (USD Million)
        6. Rest of Europe, 2023-2036F (USD Million)
  14. Asia Pacific Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. China, 2023-2036F (USD Million)
        2. India, 2023-2036F (USD Million)
        3. Japan, 2023-2036F (USD Million)
        4. Australia, 2023-2036F (USD Million)
        5. New Zealand, 2023-2036F (USD Million)
        6. Rest of APAC, 2023-2036F (USD Million)
  15. Latin America Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. Brazil, 2023-2036F (USD Million)
        2. Mexico, 2023-2036F (USD Million)
        3. Rest of LATAM, 2023-2036F (USD Million)
  16. Middle East & Africa Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. GCC, 2023-2036F (USD Million)
        2. South Africa, 2023-2036F (USD Million)
        3. Rest of MEA, 2023-2036F (USD Million)

 

Liposome Drug Delivery Market Trends

Growth Drivers

  • Rising Prevalence of Cancer Globally – Liposome drug delivery is widely used in the treatment of cancer owing to its wide range of advantages and properties. In 2020, 10 million people died out of cancer all over the globe and 5 million new cases were recorded. 
  • Growing Significance of Liposomes as a Drug Delivery System - Owing to the importance of liposomes in drug delivery, numerous studies, and clinical trials are ongoing and positive results from these sources are expected to continue to have a positive impact on the growth of the liposome drug delivery market under study. According to the study "Inhaled Liposomal Antimicrobial Delivery in Pulmonary Infections" published in July 2020, the use of inhaled liposomal antimicrobial therapy in pulmonary infections resulted in the antimicrobial agent targeting the infective organisms at the site of infection, thereby increasing the intracellular antibiotic concentration. It reduces drug toxicity and improves tolerability. 
  • Increased Use of Quality by Design (QbD) Over Traditional Methods- As a consequence of the popularity of rational-based methods like QbD over empirical and simulation-based techniques, procedures have been upgraded. In contrast to traditional techniques that rely on trial and error, QbD is based on a fact-based rational strategy that allows for superior decision-making. The popularity and application of the QbD approach are expected to propel market growth.

Challenges

  • High Cost of Development of the Drug Delivery System – Liposome drug delivery can be expensive and can limit access for patients who cannot afford it. This can be a particularly big challenge in developing countries with limited healthcare budgets. 
  • Limited Clinical Data
  • Competition from Drug Delivery Technologies

Liposome Drug Delivery Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

9.1%

Base Year Market Size (2024)

USD 5.97 billion

Forecast Year Market Size (2037)

USD 18.52 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4073
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of grouting materials is assessed at USD 6.4 billion.

The liposome drug delivery market size was over USD 5.97 billion in 2024 and is anticipated to cross USD 18.52 billion by 2037, growing at more than 9.1% CAGR during the forecast period i.e., between 2025-2037. The rising prevalence of cancer globally, and the increasing application of liposomes as a drug delivery system will drive the market growth.

North America industry is anticipated to dominate majority revenue share of 45% by 2037, impelled by increasing prevalence of cancer in the region.

The major players in the market are Spectrum Pharmaceuticals, Inc., Gilead Sciences, Inc., Celsion Corporation, Ipsen Pharma, Pacira Pharmaceuticals, Inc., Novartis AG, CordenPharma International, FUJIFILM Toyama Chemical Co., Ltd., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample